SciMatic
Journals
Thesis Rep
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
Keyword Connections
respirovirus infections / immunology*
Journals
0
No Journal Connected
Research Groups
0
No Research Group Connected
Bibliographies
33
1
Respiratory syncytial virus infection in C57BL/6 mice: clearance of virus from the lungs with virus-specific cytotoxic T cells
2
Reinfection of mice with respiratory syncytial virus
3
Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection
4
Systemic cell-mediated and antibody responses in infants with respiratory syncytial virus infections
5
Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived
6
Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization
7
Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
8
Effect of ribavirin therapy on respiratory syncytial virus-specific IgE and IgA responses after infection
9
Development of cell-mediated cytotoxic immunity to respiratory syncytial virus in human infants following naturally acquired infection
10
The appearance of cell-bound IgE in respiratory-tract epithelium after respiratory-syncytial-virus infection
11
Cell-mediated cytotoxic response to respiratory syncytial virus in infants with bronchiolitis
12
The immunologic response to infection with respiratory syncytial virus in infants
13
Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus
14
Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus
15
Cell-free and cell-bound antibody in nasal secretions from infants with respiratory syncytial virus infection
16
The 22,000-kilodalton protein of respiratory syncytial virus is a major target for Kd-restricted cytotoxic T lymphocytes from mice primed by infection
17
The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection
18
Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice
19
Dissociation between serum neutralizing and glycoprotein antibody responses of infants and children who received inactivated respiratory syncytial virus vaccine
20
Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infections
21
Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus
22
Respiratory syncytial virus infection in anti-mu-treated mice
23
CD4+ T cells clear virus but augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells
24
Local antibody production and respiratory syncytial virus infection in children with leukaemia
25
Virus-specific IgE and IgG4 antibodies in serum of children infected with respiratory syncytial virus
26
Effect of age and preexisting antibody on serum antibody response of infants and children to the F and G glycoproteins during respiratory syncytial virus infection
27
Cytolytic T-lymphocyte responses to respiratory syncytial virus: effector cell phenotype and target proteins
28
Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells
29
Defective regulation of immune responses in respiratory syncytial virus infection
30
Cell-mediated immune response to respiratory syncytial virus infection: relationship to the development of reactive airway disease
31
Interferon in nasal secretions from infants with viral respiratory tract infections
32
The antibody response to primary and secondary infection with respiratory syncytial virus: kinetics of class-specific responses
33
Secretory antibody response to respiratory syncytial virus infection